for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hitachi Chemical Co Ltd

4217.T

Latest Trade

3,400.00JPY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1,482.00

 - 

3,620.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Hitachi Chemical To Acquire Apceth Biopharma GmbH

Jan 31 (Reuters) - Hitachi Chemical Co Ltd <4217.T>::HITACHI CHEMICAL CO. LTD. TO ACQUIRE APCETH BIOPHARMA GMBH, EXPANDING GLOBAL FOOTPRINT OF ITS CELL AND GENE THERAPY CONTRACT DEVELOPMENT AND MANUFACTURING SERVICES.HITACHI CHEMICAL ADVANCED THERAPEUTICS SOLUTIONS - APCETH BIOPHARMA WILL JOIN HITACHI CHEMICAL'S PERCENT GLOBAL SERVICES PLATFORM.

Thai Storage Battery Enters License Agreement With Hitachi Chemical

Nov 12 (Reuters) - Thai Storage Battery Pcl <BAT-3K.BK>::GROUP ENTERED INTO LICENSE AGREEMENT WITH HITACHI CHEMICAL FOR USE OF HITACHI BRAND WITH RIGHT OF SUBLICENSE.RATE OF FEES BETWEEN HITACHI CHEMICAL, & CO SHALL BE 1 PERCENT OF CONSOL SALES REVENUE FOR THE BUSINESS YEAR WITH SEMIANNUAL PAYMENTS.

Hitachi Chemical Advanced Therapeutics Solutions Says Signed A Three-Year Clinical Manufacturing Agreement With GSK

Oct 1 (Reuters) - GlaxoSmithKline PLC <GSK.L>::HITACHI CHEMICAL ADVANCED THERAPEUTICS SOLUTIONS SAYS SIGNED A THREE-YEAR CLINICAL MANUFACTURING AGREEMENT WITH GSK.HITACHI CHEMICAL ADVANCED THERAPEUTICS SAYS CO TO MANUFACTURE GSK'S SPEAR T-CELL RECEPTOR THERAPY TARGETING NY-ESO-1 FOR U.S., CANADIAN, EUROPEAN TRIALS.HITACHI CHEMICAL ADVANCED THERAPEUTICS SOLUTIONS SAYS SIGNED A THREE-YEAR CLINICAL MANUFACTURING AGREEMENT WITH GSK.

affirms Hitachi Chemical's rating at "A+" and announces outlook stable -R&I

March 26(Reuters) - Hitachi Chemical Co Ltd <4217.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A+" -R&I.Says rating outlook stable -R&I.

SanBio says business alliance with Hitachi Chemical and its unit on manufacturing of SB623

March 13 (Reuters) - SanBio Co Ltd <4592.T>:Says co forms business alliance with Hitachi Chemical Co Ltd <<<4217.T>>> and its unit Hitachi Chemical Advanced Therapeutics Solutions, LCC, regarding manufacturing of SB623.

Kyowa Hakko Kirin sells 66.6 pct stake in unit Kyowa Medex

Jan 4(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it sold 66.6 percent stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd <<<4217.T>>>, on Jan. 4 .

Kyowa Hakko Kirin to sell part of stake in unit Kyowa Medex

Sept 29(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it will sell a part of stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd.<<<4217.T>>>.Price undetermined .Says the company will cut stake in Kyowa Medex to 33.4 percent .Transaction date on Jan. 4, 2018.

R&I affirms Hitachi Chemical's rating at "A+" and announces outlook stable -R&I

April 26 (Reuters) - Hitachi Chemical Co Ltd <4217.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A+" -R&I.Says rating outlook stable -R&I.

Hitachi Chemical to buy remaining 80.1% interest in PCT from Caladrius

Hitachi Chemical Co Ltd <4217.T> :Hitachi chemical signs agreement to purchase from caladrius biosciences remaining 80.1% interest in percent for $75 million.

Hitachi Chemical to pay fine of $3.8 mln to United States Department of Justice

Hitachi Chemical Co Ltd <4217.T>: Says the company will pay a fine of $3.8 million to the United States Department of Justice regarding its group company violated U.S. anti-trust laws in connection with capacitor .Says previous release was disclosed on April 28.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up